1. Home
  2. CTSO vs AGAE Comparison

CTSO vs AGAE Comparison

Compare CTSO & AGAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • AGAE
  • Stock Information
  • Founded
  • CTSO 1997
  • AGAE 2017
  • Country
  • CTSO United States
  • AGAE United States
  • Employees
  • CTSO N/A
  • AGAE N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • AGAE Cable & Other Pay Television Services
  • Sector
  • CTSO Health Care
  • AGAE Telecommunications
  • Exchange
  • CTSO Nasdaq
  • AGAE Nasdaq
  • Market Cap
  • CTSO 68.2M
  • AGAE 38.8M
  • IPO Year
  • CTSO N/A
  • AGAE N/A
  • Fundamental
  • Price
  • CTSO $0.87
  • AGAE $1.33
  • Analyst Decision
  • CTSO Strong Buy
  • AGAE
  • Analyst Count
  • CTSO 3
  • AGAE 0
  • Target Price
  • CTSO $4.67
  • AGAE N/A
  • AVG Volume (30 Days)
  • CTSO 138.7K
  • AGAE 96.8K
  • Earning Date
  • CTSO 05-14-2025
  • AGAE 05-19-2025
  • Dividend Yield
  • CTSO N/A
  • AGAE N/A
  • EPS Growth
  • CTSO N/A
  • AGAE N/A
  • EPS
  • CTSO N/A
  • AGAE N/A
  • Revenue
  • CTSO $35,594,520.00
  • AGAE $9,256,023.00
  • Revenue This Year
  • CTSO $18.72
  • AGAE N/A
  • Revenue Next Year
  • CTSO $19.75
  • AGAE N/A
  • P/E Ratio
  • CTSO N/A
  • AGAE N/A
  • Revenue Growth
  • CTSO 14.51
  • AGAE 36.15
  • 52 Week Low
  • CTSO $0.70
  • AGAE $0.61
  • 52 Week High
  • CTSO $1.61
  • AGAE $1.57
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 33.89
  • AGAE 64.64
  • Support Level
  • CTSO $0.87
  • AGAE $1.26
  • Resistance Level
  • CTSO $1.16
  • AGAE $1.50
  • Average True Range (ATR)
  • CTSO 0.07
  • AGAE 0.12
  • MACD
  • CTSO -0.02
  • AGAE 0.03
  • Stochastic Oscillator
  • CTSO 0.00
  • AGAE 71.03

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About AGAE Allied Gaming & Entertainment Inc.

Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.

Share on Social Networks: